Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
While GLP-1 receptor agonists aren't a magic bullet and won't work for everyone, they represent a significant advancement in our therapeutic arsenal
The decision was based on results from the Phase 3 TROPION-Breast02 trial, which enrolled 644 patients and compared the TROP2-directed antibody-drug conjugate against investigators choice of chemotherapy in the first-line setting
SIBO was present in 31% of patients with MCAS, and the authors concluded that mast cell mediators in the gut may contribute to altered digestive motility, which could lead to SIBO
Wolraich et al., 2019)
Combined ligand-based and structure-based design of PDE 9A inhibitors against Alzheimers disease
US$ 23.10
US$ 23.36
US$ 25.79
US$ 29.04
US$ 26.40
US$ 28.36
US$ 28.22
US$ 28.95
US$ 22.02
